Louise Scott

Louise Scott PhD is a seasoned professional in oncology drug development with extensive experience in clinical research and operations. Currently serving as Senior Director of Oncology Drug Development at Catalyst Clinical Research since May 2018, Louise has held several key positions within the organization, including Director of Clinical Services. Prior to this role, Louise held project management and clinical study management positions at Illingworth Research Group Limited and Cancer Research UK. With a notable background at Amgen, Louise managed global feasibility studies across multiple therapeutic areas, especially in oncology, and was responsible for execution of various clinical trials in the UK and Ireland. Earlier career roles included clinical research associate positions at ORION Clinical Services and The Clinical Trial Company Ltd, as well as a drug surveillance officer role at Eli Lilly and Company. Louise's academic credentials include a PhD in Molecular Medicine from Keele University and a BSc in Biochemistry from Liverpool John Moores University.